Kaleido Biosciences (NASDAQ:KLDO) Stock Continues to Trend Lower On FDA News

April 18, 2022

It is perhaps not a surprise that the Kaleido Biosciences (NASDAQ:KLDO) stock has been in the middle of a free fall over the course of the past week and during the period, it has gone down by a staggering 63%. It is not hard to figure out why the stock may have tanked. Trading Data On Thursday, KLDO stock fell 3.70% to $0.29 with more than 65.16 million shares, compared…